KC
KDNY

Kryger Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Kryger Capital’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-244,657
Closed -$9.4M – 17
2023
Q2 		$9.4M Buy
+244,657
New +$6.28M 0.96% 15

Kryger Capital's KDNY Position: Q3 2023 in Review

Kryger Capital sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 244,657 shares — an estimated $9.4M sold.

Kryger Capital first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $9.4M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

  • Kryger Capital reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Kryger Capital sold 244,657 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $9.4M.
  • Kryger Capital first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Kryger Capital's Chinook Therapeutics, Inc. Common Stock position peaked at $9.4M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Kryger Capital's 13F filing for Q3 2023, filed 14 Nov 2023.